Quantcast

Latest Carotid stenting Stories

2009-09-15 05:59:40

Among patients undergoing cardiac surgery, post-operative stroke occurred in approximately 2 percent, was not correlated with significant carotid artery narrowing, but was more common among patients who had combined cardiac and carotid procedures, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. Complications involving the blood vessels leading to the brain"”most often resulting in stroke"”are a major source of illness and...

2009-08-25 11:30:05

 Minorities have poorer results and higher rates of unnecessary surgery from a common procedure used to remove plaque from inside the carotid artery, according to a UT Southwestern Medical Center doctor who is lead author of the study in the journal Stroke.The multicenter study, available online and appearing in the July issue of the journal, found that higher rates of poor surgical outcomes for carotid endartectomy (CEA) "” a procedure performed to prevent stroke "” appeared...

2009-06-12 07:30:00

Emboshield NAV6(TM) Demonstrates Abbott's Continued Leadership in Carotid Therapy ABBOTT PARK, Ill., June 12 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the launch of the sixth-generation Emboshield NAV6(TM) Embolic Protection System for use in carotid artery stenting procedures. Carotid artery stenting provides a minimally invasive treatment alternative to conventional open carotid artery surgery for patients who are at high risk for surgery. Embolic protection systems are...

2009-05-18 03:00:00

- New data to be presented on Abbott's market-leading XIENCE V(R) stent - Educational information available on XIENCE PRIME(TM), Abbott's next-generation drug eluting stent in development BARCELONA, Spain, May 18 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the company's schedule of major events and news announcements during EuroPCR 2009 in Barcelona, May 19 - 22. These include the presentation of new data from the SPIRIT V post-approval, single-arm study of the company's...

2009-04-01 07:30:00

MOBILITY trial showcases company's leadership in developing innovative endovascular treatment options ABBOTT PARK, Ill., April 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro(TM) Peripheral Self-Expanding Stent System in patients with iliac artery disease. Iliac artery disease is a form of peripheral artery disease (PAD) that affects the lower extremities. The first patient was...

2009-03-24 07:30:00

ABBOTT PARK, Ill., March 24 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company's fully bioabsorbable drug eluting coronary stent. This second phase of the ABSORB clinical trial will enroll approximately 80 patients at 10 centers in Europe, Australia and New Zealand, and will incorporate device enhancements designed to improve deliverability and vessel support. The...

2008-12-18 07:59:00

First patient enrolled in Carotid WALLSTENT(R) Endoprosthesis registry NATICK, Mass., Dec. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in the CABANA post-market approval study of the Company's Carotid WALLSTENT(R) Monorail(R) Endoprosthesis used in conjunction with its FilterWire EZ(TM) Embolic Protection System. The first patient was enrolled in the CABANA Study by Rajesh M. Dave, M.D., Chairman, Endovascular...

2008-10-23 18:00:25

NATICK, Mass., Oct. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT(R) Monorail(R) Endoprosthesis for the treatment of patients with carotid artery disease who are at high risk for surgery. The Carotid WALLSTENT Endoprosthesis is the leading carotid stent in Europe and other international markets. The Company said it plans to launch the product immediately in the United States....

2008-10-16 15:00:27

WASHINGTON, Oct. 16 /PRNewswire/ -- The Society for Cardiovascular Angiography and Interventions (SCAI) expressed disappointment with Tuesday's decision by the Centers for Medicare and Medicaid Services (CMS) not to expand coverage of carotid artery stenting (CAS) for a greater number of patients who are at risk of stroke. CAS is a non-invasive procedure that places a stent in the carotid artery to increase blood flow in areas blocked by plaque. Currently, CMS fully covers carotid...

2008-10-16 15:00:27

Lumen Biomedical, Inc., a Minnesota-based medical device company, announced today that Principal Investigator Subbarao V. Myla, M.D. presented the results from the EPIC Clinical Trial: Evaluating the Use of the FiberNet(R) Embolic Protection System in Carotid Artery Stenting, during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, in Washington DC. The presentation was held Thursday, October 16, 2008 as...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related